Amgen Inc (AMG.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 07:02PM CEST
| Previous close | 290.45 |
| Open | 288.80 |
| Bid | 278.40 x 200000 |
| Ask | 279.15 x 300000 |
| Day's range | 278.00 - 291.00 |
| 52-week range | 197.70 - 303.00 |
| Volume | |
| Avg. volume | 168 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
BloombergInvestors Pile Into Amgen in Search of Next Obesity Drug Payout
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJudge Threatens Trump With Jail Over Gag Order ViolationsTreasury Rally Risks Running Into a $125 Billion Brick WallBuffett Praises Apple After Trimming It, Drops Paramount StakeThe shares s
Simply Wall St.Amgen First Quarter 2024 Earnings: EPS Misses Expectations
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
GuruFocus.comDecoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.